We are live on ! Find out more

950 hedge funds and large institutions have $27.9B invested in DexCom in 2024 Q4 according to their latest regulatory filings, with 193 funds opening new positions, 333 increasing their positions, 334 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 193 | Existing positions closed: 115

46% more call options, than puts

Call options by funds: $728M | Put options by funds: $499M

16% more capital invested

Capital invested by funds: $24.1B → $27.9B (+$3.84B)

7% more funds holding

Funds holding: 889950 (+61)

2.32% more ownership

Funds ownership: 89.51%91.84% (+2.3%)

0% less repeat investments, than reductions

Existing positions increased: 333 | Existing positions reduced: 334

22% less funds holding in top 10

Funds holding in top 10: 97 (-2)

Holders
950
Holders Change
+61
Holders Change %
+6.86%
% of All Funds
12.51%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.09%
New
193
Increased
333
Reduced
334
Closed
115
Calls
$728M
Puts
$499M
Net Calls
+$228M
Net Calls Change
+$248M

DXCM Hedge Fund Activity: Q4 2024 in Review

950 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2024, worth a combined $27.9B — up 16% from $24.1B a quarter earlier.

Buyers outnumbered sellers: 193 funds opened new DXCM positions and 115 closed out — a net gain of 78 holders — while 333 added to existing stakes and 334 trimmed.

The largest buyer was BlackRock, adding an estimated $339M. The largest seller was Wellington Management Group, cutting an estimated $420M.

  • 950 institutional investors held DexCom (DXCM) as of Q4 2024, up from 889 in Q3 2024.
  • Funds reported $27.9B of DexCom stock for Q4 2024, up 16% quarter-over-quarter.
  • 193 funds opened new DexCom positions in Q4 2024 and 115 closed out, a net change of +78 holders.
  • The largest DexCom buyer in Q4 2024 was BlackRock, an estimated $339M added.
  • The largest DexCom seller in Q4 2024 was Wellington Management Group, an estimated $420M sold.

Based on aggregated 13F filings for Q4 2024.